TRCT
MOR

Tower Research Capital (TRC)’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Tower Research Capital (TRC)’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,191
Closed -$21.6K – 6097
2024
Q1 		$21.6K Buy
+1,191
New +$17.6K ﹤0.01% 2934
2022
Q4 		– Sell
-5
Closed – – 6536
2022
Q3 		$0 Buy
+5
New +$26 ﹤0.01% 6621
2022
Q1 		– Sell
-421
Closed -$4K – 6702
2021
Q4 		$4K Buy
+421
New +$4.47K ﹤0.01% 5368
2021
Q3 		– Sell
-2,475
Closed -$48K – 6287
2021
Q2 		$48K Buy
+2,475
New +$53K ﹤0.01% 3060
2021
Q1 		– Sell
-141
Closed -$4K – 5814
2020
Q4 		$4K Buy
+141
New +$3.86K ﹤0.01% 4740
2020
Q3 		– Sell
-101
Closed -$3K – 5173
2020
Q2 		$3K Buy
+101
New +$2.94K ﹤0.01% 4444
2020
Q1 		– Sell
-947
Closed -$34K – 4097
2019
Q4 		$34K Buy
+947
New +$28.3K ﹤0.01% 1586
2018
Q3 		– Sell
-982
Closed -$30K – 4350
2018
Q2 		$30K Buy
+982
New +$27K ﹤0.01% 2180

Other funds holding MOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Tower Research Capital (TRC)'s MOR Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of MorphoSys AG American Depositary Shares (MOR) in Q2 2024, closing a stake of 1,191 shares — an estimated $21.6K sold.

Tower Research Capital (TRC) first reported a position in MOR in Q2 2018 and held it in 8 quarters. The position peaked at $48K in Q2 2021. 26 funds tracked by Wall St. Rank hold MOR as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining MorphoSys AG American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,191 MorphoSys AG American Depositary Shares shares in Q2 2024, an estimated $21.6K.
  • Tower Research Capital (TRC) first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s MorphoSys AG American Depositary Shares position peaked at $48K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.